1. Galal, K.M., Z. Khaled and A.M.M. Mourad, 2011. Role of cetuximab and sorafenib in treatment of metastatic colorectal cancer. Indian J. Cancer, 48: 47-54.
   CrossRef  |  Direct Link  |  
2. Alsirafy, S.A., S.M. El-Mesidi, W.A. El-Sherief, K.M. Galal, E.N. Abou-Elela and N.A. Aklan, 2011. Opioid needs of patients with advanced cancer and the morphine dose-limiting law in Egypt. J. Palliative Med., 14: 51-54.
   CrossRef  |  Direct Link  |  
3. Galal, K.M., S. El-Mesidy and S. Al-Sirafy, 2010. Causes of admission to a palliative care inpatient unit in an Egyptian cancer center. Med. J. Cairo Univ., 78: 585-589.
   Direct Link  |  
4. Galal, K., M. Galal and A.M. Mourad, 2010. Impact of pemetrexed addition to gemcitabine-oxaliplatin on treatment outcome of advanced or metastatic non-squamous non-small cell lung cancer. Afr. J. Haematol. Oncol., 1: 104-114.
   Direct Link  |  
5. Galal, K.M., M. Abdelsalam, E.E. Fawzy, S. Mansour, K. Zaghloul and E.M. Mohamed, 2008. Role of bevacizumab as post-progression maintenance therapy in metastatic colon cancer. J. Med. Sci., 8: 452-460.
   Direct Link  |